Cresco Labs ( (TSE:CL) ) just unveiled an announcement.
Cresco Labs reported record financial results for 2024, with an operating cash flow of $132 million, marking a 126% increase from the previous year. The company achieved a revenue of $724 million and maintained its leading market share in Illinois, Pennsylvania, and Massachusetts. Despite a net loss of $60 million due to one-time charges, Cresco Labs improved its adjusted EBITDA by 15% year-over-year, reflecting its disciplined strategy and strong market positioning.
More about Cresco Labs
Cresco Labs is a leading company in the cannabis industry, known for its branded cannabis products and operation of Sunnyside dispensaries. The company holds a strong market position with a portfolio of popular brands across the United States.
YTD Price Performance: -22.00%
Average Trading Volume: 730,753
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $330.2M
See more data about CL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com